Single-cell RNA sequencing technologies and applications: A brief overview
Research output: Contribution to journal › Review › Research › peer-review
Standard
Single-cell RNA sequencing technologies and applications : A brief overview. / Jovic, Dragomirka; Liang, Xue; Zeng, Hua; Lin, Lin; Xu, Fengping; Luo, Yonglun.
In: Clinical and Translational Medicine, Vol. 12, No. 3, e694, 2022.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Single-cell RNA sequencing technologies and applications
T2 - A brief overview
AU - Jovic, Dragomirka
AU - Liang, Xue
AU - Zeng, Hua
AU - Lin, Lin
AU - Xu, Fengping
AU - Luo, Yonglun
N1 - © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
PY - 2022
Y1 - 2022
N2 - Single-cell RNA sequencing (scRNA-seq) technology has become the state-of-the-art approach for unravelling the heterogeneity and complexity of RNA transcripts within individual cells, as well as revealing the composition of different cell types and functions within highly organized tissues/organs/organisms. Since its first discovery in 2009, studies based on scRNA-seq provide massive information across different fields making exciting new discoveries in better understanding the composition and interaction of cells within humans, model animals and plants. In this review, we provide a concise overview about the scRNA-seq technology, experimental and computational procedures for transforming the biological and molecular processes into computational and statistical data. We also provide an explanation of the key technological steps in implementing the technology. We highlight a few examples on how scRNA-seq can provide unique information for better understanding health and diseases. One important application of the scRNA-seq technology is to build a better and high-resolution catalogue of cells in all living organism, commonly known as atlas, which is key resource to better understand and provide a solution in treating diseases. While great promises have been demonstrated with the technology in all areas, we further highlight a few remaining challenges to be overcome and its great potentials in transforming current protocols in disease diagnosis and treatment.
AB - Single-cell RNA sequencing (scRNA-seq) technology has become the state-of-the-art approach for unravelling the heterogeneity and complexity of RNA transcripts within individual cells, as well as revealing the composition of different cell types and functions within highly organized tissues/organs/organisms. Since its first discovery in 2009, studies based on scRNA-seq provide massive information across different fields making exciting new discoveries in better understanding the composition and interaction of cells within humans, model animals and plants. In this review, we provide a concise overview about the scRNA-seq technology, experimental and computational procedures for transforming the biological and molecular processes into computational and statistical data. We also provide an explanation of the key technological steps in implementing the technology. We highlight a few examples on how scRNA-seq can provide unique information for better understanding health and diseases. One important application of the scRNA-seq technology is to build a better and high-resolution catalogue of cells in all living organism, commonly known as atlas, which is key resource to better understand and provide a solution in treating diseases. While great promises have been demonstrated with the technology in all areas, we further highlight a few remaining challenges to be overcome and its great potentials in transforming current protocols in disease diagnosis and treatment.
KW - Animals
KW - Gene Expression Profiling/methods
KW - Sequence Analysis, RNA/methods
KW - Single-Cell Analysis/methods
KW - Technology
KW - Whole Exome Sequencing
U2 - 10.1002/ctm2.694
DO - 10.1002/ctm2.694
M3 - Review
C2 - 35352511
VL - 12
JO - Clinical and Translational Medicine
JF - Clinical and Translational Medicine
SN - 2001-1326
IS - 3
M1 - e694
ER -
ID: 310505725